outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,419,7276.4542943,1022.2886562,51792.404012,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4785,1787,0.2898262709,0.1206043119,0.6964864353,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4841,4181,0.7003923628,0.474392186,1.0340588995,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1756,0.2133012346,0.0262652802,1.7322265895,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4785,7934,0.3687052951,0.1841338085,0.7382869869,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4841,17774,0.5378987814,0.3995754645,0.7241062695,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,419,7896.514385,1106.6783533,56344.229783,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4785,1787,0.6371597601,0.1969290205,2.0615171843,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4841,4181,0.7415314982,0.4820898149,1.1405944408,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1756,0.227973833,0.0280029128,1.8559522323,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4785,7934,0.8256846456,0.2922087207,2.3331101559,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4841,17774,0.5488351525,0.3900065842,0.7723459981,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,419,8037.0382779,1127.4885881,57290.144629,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4785,1787,0.6485067032,0.2033414406,2.0682500465,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4841,4181,0.7689817381,0.5027971435,1.1760864621,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1756,0.2265860701,0.0278190123,1.8455452911,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4785,7934,0.8202159007,0.2885032877,2.3318768018,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4841,17774,0.5440782449,0.3837575507,0.7713754061,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,419,7820.6063549,1096.404492,55784.050687,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4785,1787,0.6173678037,0.188593439,2.020977013,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4841,4181,0.7076850167,0.4606728811,1.0871447037,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1756,0.2298106641,0.0282238776,1.8712149371,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4785,7934,0.8258693733,0.2921541316,2.3345903683,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4841,17774,0.5530831599,0.3929054677,0.7785612746,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1081,419,7895.0471255,1106.4883695,56332.963665,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4785,1787,0.6370818461,0.1968877092,2.0614454824,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4841,4181,0.7403951102,0.4816981623,1.1380257642,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1081,1756,0.2278928252,0.0279931831,1.8552781115,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4785,7934,0.8255342677,0.2921134925,2.3330207086,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4841,17774,0.5484445391,0.3898626499,0.7715317498,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1081,419,8004.997969,1123.1152283,57055.581536,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4785,1787,0.6355357566,0.1978363147,2.0416155578,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4841,4181,0.7378664296,0.4833747228,1.1263453429,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1081,1756,0.2279275712,0.0279803748,1.8566934165,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4785,7934,0.8181447806,0.28747553,2.3284099419,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4841,17774,0.5466575115,0.3856676216,0.7748496845,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.6061685428,0.4688301284,5.5025844796,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,0.7694526019,0.4656029643,1.2715926485,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4860,4230,0.8684853933,0.7092668538,1.0634458305,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,1.2331191269,0.6350080532,2.3945881844,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.9072076352,0.6412171234,1.2835366731,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17880,0.6833695434,0.5924760021,0.7882073388,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.8188948396,0.5068411949,6.5274458173,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,0.7411881557,0.4077499569,1.3472959908,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4860,4230,1.3207432958,1.0449828691,1.6692741143,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,1.4525152605,0.6916408372,3.0504280094,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.9507853405,0.6396515416,1.4132581647,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17880,0.9920608293,0.8272031306,1.1897738932,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,1.9255304422,0.5372167685,6.9016227735,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4790,1793,0.7890017161,0.4324620726,1.4394874081,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4860,4230,1.3967660876,1.1058227849,1.7642569226,1,1
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.4317940668,0.6819408192,3.0061761842,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.9352782739,0.6287156768,1.3913211995,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4860,17880,0.9667892375,0.8050455013,1.1610293186,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,420,1.7903522796,0.4992426397,6.4204477547,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4790,1793,0.7057730654,0.3882937476,1.2828319357,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4860,4230,1.2432465526,0.9823058398,1.5735038193,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.4703410715,0.7002902192,3.0871527364,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.9468700687,0.6367948344,1.4079305902,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4860,17880,1.0039300131,0.8371695009,1.2039084918,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1082,420,1.8198160897,0.5070880009,6.5308794422,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4790,1793,0.7413530012,0.4078515631,1.3475595586,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4860,4230,1.3236468338,1.0475721129,1.6724776452,1,1
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.4534604063,0.692080217,3.0524599614,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.9510667724,0.6398263025,1.4137086926,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4860,17880,0.9930340491,0.828146993,1.1907507133,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1082,420,1.9224437214,0.5369394156,6.8830667946,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4790,1793,0.7628040976,0.4178025855,1.3926914564,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4860,4230,1.3269923768,1.0497548234,1.677447656,1,1
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1082,1756,1.4460596794,0.6888527983,3.0356102226,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.9304545431,0.625242322,1.3846561985,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4860,17880,0.9768985843,0.8138671967,1.1725879208,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1071,416,1.1032294871,0.4462303597,2.7275492906,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4735,1748,0.538046474,0.3765012359,0.7689058645,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4643,3984,0.7839800201,0.6627248095,0.9274206475,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1071,1737,0.4979488395,0.3034052191,0.8172339537,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4735,7849,0.473560574,0.3715566738,0.6035677274,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4643,17315,0.4736381694,0.4186980105,0.535787393,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,1071,416,2.3871815,0.8950671958,6.3667125116,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4735,1748,0.7664125189,0.5111096102,1.149241058,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,4643,3984,1.2515429153,1.0231765494,1.530879172,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1071,1737,0.9566120885,0.5204000187,1.7584678231,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4735,7849,0.6484462397,0.4878444236,0.8619193033,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4643,17315,0.7717492964,0.6561427612,0.9077246778,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1071,416,2.399507554,0.9000408924,6.397083233,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4735,1748,0.7703636051,0.5135991338,1.1554927664,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4643,3984,1.2621509385,1.0337461845,1.5410213991,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1071,1737,0.9564962191,0.5199257082,1.7596456624,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4735,7849,0.6476176092,0.4867734864,0.8616093101,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4643,17315,0.768372939,0.6518237299,0.9057617058,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1071,416,2.3713946281,0.8891083789,6.3248897615,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4735,1748,0.7487891324,0.4992100057,1.1231448856,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4643,3984,1.2063686909,0.9873993254,1.4738975216,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1071,1737,0.9609744556,0.5229832098,1.7657773459,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4735,7849,0.6487889087,0.4880920567,0.8623927438,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4643,17315,0.7779450642,0.6611369345,0.9153905816,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1071,416,2.3808160969,0.8927168806,6.3494769846,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4735,1748,0.7655574193,0.5105258903,1.1479891098,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4643,3984,1.2355029094,1.0105674265,1.5105052856,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1071,1737,0.955683953,0.5199003292,1.7567440654,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4735,7849,0.6475803108,0.4872019388,0.8607524428,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4643,17315,0.769015977,0.6540430682,0.904199741,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1071,416,2.4082868988,0.9031749462,6.4216194344,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4735,1748,0.7612302617,0.5071478896,1.1426085431,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4643,3984,1.2127666007,0.994529337,1.478893355,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1071,1737,0.9569067948,0.5203473862,1.7597294389,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4735,7849,0.6444164079,0.4843705343,0.8573446925,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4643,17315,0.767708786,0.6514246321,0.9047505283,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1070,419,21734.104754,11565.005381,40844.884537,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4766,1782,0.619604592,0.3348492573,1.1465154604,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4731,4106,0.6717881003,0.5459656368,0.8266074296,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1749,0.7786867719,0.3621318033,1.6743988879,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4766,7915,0.5705383193,0.3846276135,0.8463094232,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4731,17600,0.5146757663,0.4387823354,0.6036960083,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,1070,419,29264.3472,14406.846997,59444.097462,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4766,1782,1.093582831,0.5134782743,2.3290633081,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,4731,4106,1.0586330723,0.8217279531,1.3638382114,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1749,1.1976538035,0.5222876668,2.7463306607,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4766,7915,0.9703695472,0.5491559822,1.7146622976,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4731,17600,0.7949121183,0.6416791012,0.9847371913,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1070,419,29287.176549,14409.294517,59526.766508,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4766,1782,1.0842049347,0.5119835909,2.2959726858,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4731,4106,1.0640075277,0.833342114,1.3585201085,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1070,1749,1.2024203924,0.5241746506,2.758269211,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4766,7915,0.9732141925,0.5540052989,1.7096332227,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4731,17600,0.7893762229,0.6317951732,0.9862608133,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1070,419,29094.979927,14323.882436,59098.352747,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4766,1782,1.0739734941,0.5053178429,2.2825615246,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4731,4106,1.0306086638,0.79926027,1.3289215763,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1070,1749,1.2020577464,0.524194865,2.7564993902,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4766,7915,0.9694424161,0.5489019968,1.7121792297,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4731,17600,0.7976964132,0.6439131985,0.9882070582,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1070,419,29273.670171,14411.587566,59462.412544,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4766,1782,1.0929516579,0.5132036896,2.3276203011,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4731,4106,1.0513331381,0.8168391188,1.3531445077,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1070,1749,1.1957782605,0.5214869841,2.7419392847,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4766,7915,0.9696725098,0.5488077364,1.7132863,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4731,17600,0.7927484557,0.6402526605,0.9815657987,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1070,419,29330.882073,14433.546866,59604.243584,0,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4766,1782,1.0723860715,0.5072994938,2.2669289056,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4731,4106,1.0344634082,0.8091843048,1.3224608245,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1070,1749,1.2028753294,0.5243824584,2.7592628907,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4766,7915,0.9689457589,0.552751446,1.6985136635,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4731,17600,0.7871285863,0.6304957881,0.9826733549,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,420,6558.5393749,2107.1851953,20413.221784,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4768,1783,0.950694829,0.4808344579,1.8796919462,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4760,4127,0.7777778503,0.6354303635,0.9520136576,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1753,0.4853993161,0.131675298,1.7893446961,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4768,7899,0.5822499447,0.4043590719,0.8384008709,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4760,17554,0.5401142705,0.4649436974,0.6274381756,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,420,6712.8847029,1673.1849454,26932.361039,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4768,1783,1.3068308145,0.5290388591,3.2281310691,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,4760,4127,1.2689239807,0.9856885524,1.6335464837,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1753,0.5198628723,0.1121621935,2.4095231877,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4768,7899,0.9229667165,0.5614738368,1.5171990283,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4760,17554,0.8555157022,0.6929779671,1.0561766052,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,420,6830.7489794,1702.4635865,27406.830896,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4768,1783,1.3220992573,0.5373233389,3.2530625783,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4760,4127,1.2996240738,1.0147518977,1.6644686617,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1753,0.517200464,0.1115587975,2.3978056938,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4768,7899,0.9159391875,0.5557066112,1.5096897865,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4760,17554,0.8449123962,0.6816105591,1.047338466,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,420,6671.4078045,1660.9775568,26796.076751,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4768,1783,1.2789039226,0.5171563147,3.162670931,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4760,4127,1.233939503,0.9541229072,1.5958181967,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1753,0.5223295836,0.1126342359,2.4222492554,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4768,7899,0.9211617312,0.5603885667,1.5141974433,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4760,17554,0.8591908063,0.6961420595,1.060428445,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1081,420,6764.0218219,1685.8678424,27138.539604,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4768,1783,1.3082995789,0.5296038441,3.2319398873,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4760,4127,1.2838154138,0.993387491,1.659153182,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1081,1753,0.5214103724,0.1124950862,2.4167169052,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4768,7899,0.9243377491,0.5622904706,1.5194998298,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4760,17554,0.8594958154,0.6951319576,1.0627234852,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1081,420,6848.3954755,1705.1839629,27504.669061,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4768,1783,1.2969440885,0.5267559623,3.1932509344,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4760,4127,1.2789822979,0.9917287548,1.6494386297,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1081,1753,0.5213784947,0.112391542,2.4186476125,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4768,7899,0.9147811337,0.5549502877,1.5079270001,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4760,17554,0.8532552801,0.6865461529,1.0604452009,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1079,420,26833.344291,11081.388855,64976.3649,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4780,1788,0.7662512214,0.2759261568,2.1278915384,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4816,4187,0.571760838,0.4306917374,0.7590358195,1,1
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1755,2.4399030568,0.5828457035,10.21389862,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4780,7920,0.5983125525,0.3194005924,1.1207803587,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4816,17731,0.517896559,0.4130935672,0.6492883626,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,1079,420,65136.960087,22048.510079,192431.30508,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4780,1788,1.5019025132,0.3845199039,5.8663053225,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,4816,4187,0.8734641585,0.621044136,1.2284789306,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1079,1755,6.0437296549,1.2485960789,29.254190973,1,1
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4780,7920,1.0559543925,0.3564331481,3.1283276683,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4816,17731,0.7666411311,0.5736818949,1.0245026541,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1079,420,73490.581297,24967.044645,216319.77738,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4780,1788,1.5544650308,0.404916964,5.9675482797,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4816,4187,0.9517879806,0.6743479221,1.3433723606,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1079,1755,6.0107840148,1.2399863329,29.137034429,1,1
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4780,7920,1.0453517983,0.3627324775,3.0125793802,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4816,17731,0.735916667,0.5422063254,0.998832576,1,1
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1079,420,64651.478616,21864.741463,191166.84706,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4780,1788,1.4671657148,0.377522279,5.7018495448,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4816,4187,0.848577048,0.5978298399,1.2044949219,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1079,1755,6.0854712677,1.2565549608,29.471819144,1,1
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4780,7920,1.0533537723,0.3560588442,3.1162101088,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4816,17731,0.7701754227,0.5769194739,1.0281680695,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1079,420,68387.564587,23141.654027,202097.00589,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4780,1788,1.5060355672,0.3856070021,5.8820071141,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4816,4187,0.898727057,0.6378885627,1.2662248081,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1079,1755,6.099617628,1.2602704086,29.521708161,1,1
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4780,7920,1.0589224182,0.3574901812,3.136636324,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4816,17731,0.7780173538,0.5817466379,1.0405062331,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1079,420,78027.700044,26481.89908,229905.03649,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4780,1788,1.5188425394,0.3959607759,5.8260383353,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4816,4187,0.9485328159,0.6658305769,1.3512664242,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1079,1755,6.1128536577,1.2605126905,29.644271036,1,1
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4780,7920,1.0447462995,0.3634930309,3.0027943798,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4816,17731,0.7535125176,0.5546917184,1.0235976045,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.3534987187,0.6713413392,2.7288037761,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,0.9002756759,0.7270535193,1.1147684057,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4860,4230,0.7910826976,0.728793971,0.8586951311,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,0.8248349777,0.5717998131,1.1898442861,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.7250151014,0.6382067397,0.8236310658,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17880,0.6670205651,0.6272926569,0.7092645344,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,2.1069348046,0.9903604058,4.4823826205,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,1.0368397755,0.7953730376,1.3516132296,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4860,4230,0.87969886,0.7941189274,0.974501498,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,1.1900253394,0.7796901472,1.8163116635,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.8858120376,0.7395967738,1.0609334623,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17880,0.7489787638,0.6887075375,0.8145245377,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,2.2692051186,1.066251168,4.8293423025,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4790,1793,1.1193047136,0.8592766057,1.4580206578,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4860,4230,0.9559239461,0.863547459,1.0581822473,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.1642839482,0.7630010219,1.7766124463,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.8616551505,0.7203385116,1.0306954112,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4860,17880,0.7145756632,0.6557983898,0.7786209701,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,420,2.1159097639,0.9956480108,4.496643473,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4790,1793,1.0569670558,0.8109389523,1.3776368171,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4860,4230,0.9041569934,0.8157655166,1.0021260425,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.1844667855,0.7761176602,1.8076660768,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.8875581324,0.7409906134,1.0631166228,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4860,17880,0.7475138387,0.6876154027,0.81263005,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1082,420,2.1428022181,1.0042014826,4.5723905268,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4790,1793,1.042874908,0.7998295247,1.3597748522,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4860,4230,0.9486022425,0.8525454404,1.0554818218,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.1755609356,0.768153477,1.7990460953,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.8627391538,0.7199960219,1.0337818888,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4860,17880,0.7363975153,0.6755133063,0.8027692357,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1082,420,2.2526369019,1.0563063833,4.8038836952,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4790,1793,1.1082083935,0.8511289766,1.4429374127,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4860,4230,1.0284392642,0.9252561977,1.1431291385,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1082,1756,1.1511081598,0.7526166602,1.760590837,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4790,7949,0.8501568529,0.7099755234,1.018016327,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4860,17880,0.7088875331,0.6494932916,0.7737132025,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,0.8937962916,0.3256508505,2.4531543814,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,0.8795450604,0.602192416,1.2846384191,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4860,4230,0.8762192679,0.7438759758,1.0321078115,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,1.4739641315,0.7193145935,3.0203339134,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7949,1.3298365151,1.0264123923,1.7229577216,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17880,0.9524226983,0.8409871134,1.0786241332,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,0.6615245251,0.2297865334,1.9044401377,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,1.0342673362,0.6518092325,1.6411380344,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,4860,4230,0.9730095727,0.7903708073,1.197852476,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,1.3196394863,0.6191858438,2.8124809234,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7949,1.2600829556,0.8766406028,1.8112428854,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4860,17880,1.0496760641,0.88104323,1.2505854446,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,0.6959324926,0.2414348534,2.0060154009,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4790,1793,1.0865596254,0.685717842,1.7217166411,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4860,4230,1.0340316542,0.8437942252,1.267159018,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.2957986734,0.6080152432,2.7615988591,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4790,7949,1.2330504429,0.8560394711,1.7761019744,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4860,17880,1.018620014,0.8506683295,1.2197312361,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,420,0.6710802889,0.2326791859,1.9354922203,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4790,1793,1.0713385264,0.6754217676,1.6993326143,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4860,4230,1.020027674,0.8271341154,1.2579053824,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.3084004134,0.6136018422,2.7899388888,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4790,7949,1.2647563546,0.8802316912,1.8172586289,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4860,17880,1.0414805661,0.8742680211,1.2406741906,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1082,420,0.6666505446,0.2314575701,1.9201054796,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4790,1793,1.0342427343,0.6519431137,1.640722957,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4860,4230,1.0042246283,0.8129898705,1.2404423974,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.3323508473,0.6249912094,2.8402939974,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4790,7949,1.2651563863,0.8802094099,1.8184544085,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4860,17880,1.0609200827,0.8899381373,1.2647524303,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1082,420,0.6978177945,0.2416898997,2.0147704757,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4790,1793,1.0988916031,0.6938226885,1.7404486411,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4860,4230,1.0889174782,0.8866533541,1.337322268,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1082,1756,1.3013069859,0.6101866056,2.7752163945,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4790,7949,1.2486396025,0.8671435754,1.7979731398,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4860,17880,1.0251253194,0.8542662944,1.2301573026,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1033,406,1.5787289366,0.6026929288,4.1354144646,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4596,1732,2.3202337403,1.3299040132,4.0480249374,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4511,3967,1.4703415145,1.0973101115,1.9701852253,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1033,1728,1.0345591714,0.6170774959,1.7344866505,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4596,7836,1.5156183706,1.1612157777,1.9781844936,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4511,17524,1.0451215698,0.863205989,1.2653747883,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1033,406,1.9062189025,0.6994443824,5.1950814043,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4596,1732,2.453944988,1.3498906989,4.4609878483,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4511,3967,1.7704402042,1.2452803651,2.5170705364,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1033,1728,1.0575521797,0.5901588917,1.8951110094,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4596,7836,1.4847205395,1.0960021364,2.0113054594,1,1
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4511,17524,1.2468405732,0.9566678476,1.6250273477,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1033,406,2.0547040939,0.752207476,5.6125590987,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4596,1732,2.6588747925,1.4562684265,4.8546099285,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4511,3967,1.9445918358,1.3589536044,2.7826096459,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1033,1728,1.0372845144,0.5782131044,1.8608349686,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4596,7836,1.4569975593,1.0744132723,1.9758150263,1,1
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4511,17524,1.2134874125,0.9305739317,1.5824123697,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1033,406,1.9071674589,0.6997748926,5.1977968272,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4596,1732,2.4597744446,1.3530893431,4.4716118334,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4511,3967,1.7764776863,1.251906463,2.5208536445,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1033,1728,1.0570162903,0.589938553,1.893897987,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4596,7836,1.4847341739,1.0960279052,2.0112951111,1,1
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4511,17524,1.2460999971,0.9554224433,1.6252132382,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1033,406,1.9030651965,0.6983071802,5.1863381112,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4596,1732,2.4516114074,1.3486446439,4.4566213347,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4511,3967,1.7479824014,1.2277703563,2.4886107241,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1033,1728,1.0574813253,0.5901131847,1.8950038438,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4596,7836,1.4816758145,1.0938066303,2.0070853097,1,1
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4511,17524,1.2399163813,0.9505477469,1.617375495,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1033,406,2.0630798482,0.755194963,5.6360260175,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4596,1732,2.668768576,1.4617778133,4.8723722905,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4511,3967,1.9210923733,1.3433053583,2.747399081,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1033,1728,1.0365916796,0.5778872018,1.8593980053,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4596,7836,1.4513523093,1.0702319602,1.9681934423,1,1
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4511,17524,1.2027373845,0.9208294006,1.5709502923,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1061,413,5.7396490405,0.7654928321,43.035766931,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4679,1770,1.0051339514,0.6256793355,1.6147157226,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4691,4073,1.3789290723,1.0409157965,1.8267043239,1,1
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1061,1740,1.0868539139,0.5924383753,1.9938806791,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4679,7894,1.2698842947,0.9562362885,1.6864096682,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4691,17700,1.2682064725,1.0470990519,1.5360033552,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1061,413,7.6342007354,0.9775728496,59.618084619,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4679,1770,0.706554659,0.4140661174,1.2056516221,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4691,4073,1.6721703938,1.1703766566,2.3891059431,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1061,1740,0.9808362828,0.4310534725,2.2318340417,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4679,7894,1.104066364,0.8025163793,1.5189254296,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4691,17700,1.4581647038,1.0945365117,1.9425978764,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1061,413,7.9262233947,1.0145291355,61.925296282,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4679,1770,0.7330633607,0.4298669877,1.2501120259,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4691,4073,1.7293867474,1.2075261137,2.4767816513,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1061,1740,0.9708383964,0.4263042195,2.2109262562,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4679,7894,1.0899615148,0.7905753822,1.5027233713,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4691,17700,1.4356834905,1.0797692922,1.9089143393,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1061,413,7.6500666621,0.9795776016,59.74362811,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4679,1770,0.7118092501,0.4161964425,1.2173876487,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4691,4073,1.6895033613,1.1919321056,2.3947854031,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1061,1740,0.9794462001,0.4303317593,2.2292448516,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4679,7894,1.1043688733,0.8027412886,1.5193321007,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4691,17700,1.4557350654,1.090586556,1.943142036,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1061,413,7.6243141545,0.9762462401,59.54457384,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4679,1770,0.705702261,0.4135801727,1.2041575348,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4691,4073,1.6607306953,1.1644652204,2.3684919,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1061,1740,0.9804624098,0.4308945676,2.2309553413,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4679,7894,1.1031439939,0.8018712354,1.5176085855,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4691,17700,1.4540494694,1.0924734237,1.9352963777,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1061,413,7.9337249576,1.0153787051,61.99065569,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4679,1770,0.7374060192,0.4319283574,1.2589301624,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4691,4073,1.7343729872,1.2214142604,2.4627595701,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1061,1740,0.9689872304,0.4254306093,2.2070256162,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4679,7894,1.0884019042,0.789227051,1.5009859374,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4691,17700,1.4281488714,1.0736467135,1.8997023633,1,1
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1081,419,832907.18944,265882.55544,2609176.0141,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4787,1792,365435.0073,163715.45607,815700.28733,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4849,4220,1.7465844467,0.7720222843,3.9513849423,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1755,4.368458642,0.4536032317,42.070756053,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4787,7946,1.6651688263,0.5090437518,5.4470508868,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4849,17863,1.180960626,0.7044680593,1.9797462519,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,1081,419,883851.63784,259769.1346,3007261.5013,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4787,1792,193286.10812,83277.560326,448614.48206,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,4849,4220,2.5819035737,1.0515859453,6.3392118292,1,1
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1081,1755,5.727162928,0.572186979,57.324609626,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4787,7946,1.1456681296,0.3405031065,3.8547532699,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4849,17863,1.5437198478,0.8268527448,2.8820983946,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1081,419,873653.47091,251075.67208,3040001.3706,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4787,1792,191321.96647,80559.600828,454372.84293,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4849,4220,2.609515437,1.0951457235,6.2179586423,1,1
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1081,1755,5.7256655137,0.572959363,57.217400899,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4787,7946,1.1532677371,0.3436021628,3.8708326591,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4849,17863,1.5640295316,0.8159130542,2.9980993236,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1081,419,890652.77162,261792.41097,3030119.768,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4787,1792,200884.5414,86397.349616,467081.44584,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4849,4220,2.7101054471,1.0691828876,6.8694248849,1,1
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1081,1755,5.6736686343,0.5662211708,56.851487421,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4787,7946,1.1502381847,0.3418191707,3.8706076047,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4849,17863,1.5340191853,0.8256288323,2.8502091603,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1081,419,894866.86015,262945.62985,3045445.9268,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4787,1792,194591.03661,83819.756134,451751.15363,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4849,4220,2.6206304724,1.067026536,6.4363011051,1,1
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1081,1755,5.7535826048,0.5748346256,57.588237233,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4787,7946,1.1466156635,0.3407345241,3.8585097392,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4849,17863,1.5537452684,0.8316054461,2.9029684335,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1081,419,882352.50997,253242.23329,3074313.2444,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4787,1792,197971.17534,83650.752033,468526.40668,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4849,4220,2.7423359849,1.1223426947,6.7006331396,1,1
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1081,1755,5.7165922602,0.5714157145,57.190284129,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4787,7946,1.1639002552,0.3465469876,3.9090335577,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4849,17863,1.5725984032,0.8191708553,3.0189864808,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,801801.29974,197398.43359,3256790.4039,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4788,1793,0.2868407689,0.0402476795,2.0442824965,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4854,4223,1.4638126099,0.6154223488,3.4817509654,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,796316.24901,197492.58686,3210852.5111,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4788,7949,0.7092498181,0.1297307726,3.8775326333,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4854,17874,2.0842655702,1.1480716383,3.7838779586,1,1
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,906538.97993,203673.20839,4034958.3955,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4788,1793,0.546165946,0.0608240211,4.9042670148,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4854,4223,1.3215931054,0.4930928861,3.5421487222,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,901922.97607,204326.88089,3981194.5018,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4788,7949,1.1499789824,0.1619892507,8.163823553,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4854,17874,1.7173803093,0.7859033528,3.7528725589,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,863361.51912,192935.76577,3863426.3053,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4788,1793,0.5081489052,0.0579848948,4.4531478529,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4854,4223,1.2715148205,0.4861400745,3.3256874376,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1756,948837.53224,214843.03409,4190467.0841,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4788,7949,1.1709858938,0.1632852922,8.3976207814,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4854,17874,1.7389961589,0.7741099443,3.9065608998,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,420,905351.66893,203880.83752,4020297.613,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4788,1793,0.5431205283,0.0596511134,4.945086377,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4854,4223,1.3106416205,0.4641787896,3.7006892515,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1756,902985.40357,204139.49323,3994242.4963,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4788,7949,1.1499792507,0.1619778158,8.1644036898,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4854,17874,1.7196870847,0.7946631871,3.7214806442,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1082,420,949785.40274,213498.87937,4225278.905,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4788,1793,0.5491755755,0.0611867126,4.9290736503,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4854,4223,1.3611193434,0.514737631,3.5992042462,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1082,1756,945213.99925,214262.4205,4169790.9615,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4788,7949,1.155193343,0.1627718231,8.1984193251,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4854,17874,1.7341833971,0.7974930019,3.7710576114,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1082,420,900470.93509,201501.24929,4024034.1328,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4788,1793,0.5051009773,0.0569261984,4.4817150039,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4854,4223,1.2939447407,0.4805217735,3.4843228433,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1082,1756,999304.80033,226144.89758,4415797.5468,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4788,7949,1.1786261585,0.163857906,8.4778309155,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4854,17874,1.7711292533,0.8004813582,3.9187656273,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.01063051,0.8840708123,1.1553079387,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4788,1792,1.1212398501,0.1252555955,10.036907307,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4837,4189,0.556697966,0.3684960449,0.8410202216,1,1
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,1.0000899493,0.9165859587,1.0912014276,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4788,7944,2.8009118051,0.5131641168,15.28771534,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4837,17824,0.9997470781,0.7034319104,1.420882683,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.0213795872,0.8663404124,1.2041643749,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4788,1792,1.1074753599,0.1223777681,10.022258876,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,4837,4189,0.9662528735,0.5640563088,1.6552329991,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1756,1.0113100807,0.9051505989,1.1299203476,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4788,7944,2.0312502574,0.3532518832,11.67998758,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4837,17824,1.7427152187,1.063112532,2.8567590375,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,1.1631447693,0.942905737,1.4348260926,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4788,1792,1.3751455503,0.1514554543,12.48568626,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4837,4189,1.1921491026,0.7087942128,2.0051228653,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1756,0.9854689708,0.8669192222,1.1202301986,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4788,7944,1.8765949815,0.3254906497,10.819385219,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4837,17824,1.5776647927,0.9499262084,2.6202311045,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,420,1.0277829464,0.8702685974,1.2138066201,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4788,1792,1.1277448527,0.1244824341,10.216770435,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4837,4189,0.9893816343,0.5833246135,1.6780982589,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.0071156576,0.8988328095,1.1284433959,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4788,7944,2.0336297913,0.3536469513,11.694290346,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4837,17824,1.7365391246,1.0566397827,2.8539225767,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1082,420,1.0234850133,0.8672858909,1.2078157658,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4788,1792,1.1098043131,0.1226294801,10.043797077,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4837,4189,0.9801530539,0.5728942134,1.676923918,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1082,1756,1.0140756957,0.9065313536,1.1343783231,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4788,7944,2.0355055601,0.3539760078,11.70498224,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4837,17824,1.7535463934,1.0704753581,2.8724855088,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1082,420,1.1765985803,0.9484944514,1.459559639,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4788,1792,1.3748652382,0.1514481676,12.481197051,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4837,4189,1.2067358656,0.7257896375,2.0063822549,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1082,1756,0.9901112223,0.8699738629,1.1268387181,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4788,7944,1.8809698191,0.3261581772,10.847642977,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4837,17824,1.5798550136,0.9487017752,2.6309024916,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1077,418,19818.141485,9816.1388214,40011.529898,0,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4765,1778,1.0581065473,0.5612751234,1.9947249016,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4733,4089,0.8920284799,0.7302633389,1.089627216,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1748,0.5325950058,0.2370344615,1.1966928288,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4765,7904,0.8164554213,0.5673499233,1.1749353046,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4733,17660,0.8565215175,0.7381661444,0.9938536405,1,1
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,1077,418,22961.0162,9419.7927951,55968.138198,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4765,1778,1.2481006285,0.5270031904,2.9558742852,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,4733,4089,1.0530284398,0.8345774122,1.3286591259,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1748,0.7008441251,0.2636642489,1.8629089446,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4765,7904,1.1109001831,0.6564122907,1.8800671992,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4733,17660,0.972098318,0.8071422316,1.1707665673,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1077,418,24296.588826,9966.6518723,59229.943629,0,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4765,1778,1.3084105964,0.5539051925,3.0906702301,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4733,4089,1.108932852,0.8837703115,1.3914611684,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1077,1748,0.6915318796,0.2601268259,1.8383968624,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4765,7904,1.0928579153,0.6513800935,1.833550695,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4733,17660,0.9421211779,0.7756831264,1.1442717827,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1077,418,22892.077418,9398.1050834,55760.943705,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4765,1778,1.2336858263,0.5214506207,2.9187437076,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4733,4089,1.0370781951,0.8228004458,1.3071592125,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1077,1748,0.7031682694,0.2645229089,1.869197708,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4765,7904,1.1104312069,0.6563258673,1.8787275144,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4733,17660,0.9743669661,0.8088346886,1.1737762958,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1077,418,23323.292843,9567.8180741,56854.758818,0,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4765,1778,1.2479560863,0.5269395468,2.9555466138,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4733,4089,1.0699958411,0.8475916895,1.3507578166,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1077,1748,0.7037648442,0.2647342513,1.8708759956,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4765,7904,1.1133496571,0.6578028916,1.8843752053,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4733,17660,0.9799311163,0.8132003065,1.1808468159,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1077,418,24565.415662,10079.71204,59868.738732,0,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4765,1778,1.2893792667,0.5459047244,3.0454011832,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4733,4089,1.1032882622,0.8791915004,1.3845049559,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1077,1748,0.6969454816,0.2621436163,1.8529270754,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4765,7904,1.0952035262,0.6531490325,1.8364426866,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4733,17660,0.953387495,0.7840526119,1.1592942895,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.0074304938,0.8797610248,1.1536271456,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,0.5734684622,0.0524845734,6.2659569443,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4857,4225,7.4168760075,0.9459986303,58.150242454,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1754,1.0025250586,0.9172284652,1.0957537095,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7948,2319974.5623,584412.79603,9209726.4235,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4857,17865,1.3396464574,0.6519951681,2.7525551089,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.0193798623,0.8467814667,1.2271587707,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4790,1793,1.2147750861,0.1114794022,13.237230201,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,4857,4225,9.4639744296,1.1167707515,80.201609761,1,1
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1754,1.0056616611,0.8866974368,1.1405867825,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4790,7948,1108829.5137,281649.61085,4365363.3562,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4857,17865,1.372896913,0.5524029124,3.4120854385,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,0.9878518816,0.7572733908,1.2886380955,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4790,1793,1.1935007278,0.1102692983,12.917865703,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4857,4225,8.8578180756,1.0117379616,77.550654458,1,1
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1754,1.0115145778,0.879314148,1.1635906728,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4790,7948,3096128.0983,772576.11608,12407850.827,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4857,17865,1.3982789201,0.5711270707,3.4233781562,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,420,1.0537303101,0.8573444002,1.2951009725,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4790,1793,1.3274970755,0.1224231888,14.39472785,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4857,4225,10.588448255,1.2027380309,93.216671942,1,1
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1754,0.9822061934,0.851393254,1.1331179826,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4790,7948,1116592.5607,283403.65316,4399304.4289,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4857,17865,1.3518948966,0.5492556302,3.3274484793,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1082,420,1.0163180141,0.8437044613,1.2242465853,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4790,1793,1.2132443892,0.1113396325,13.220467091,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4857,4225,9.3462335996,1.1076826943,78.860203331,1,1
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1082,1754,1.0022268521,0.883138486,1.1373738988,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4790,7948,1109843.3295,281973.42889,4368327.2603,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4857,17865,1.365444433,0.5527518002,3.3730120804,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1082,420,1.0096962644,0.7676357694,1.3280862969,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4790,1793,1.3041925315,0.1208389891,14.075905229,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4857,4225,9.7823850202,1.084294094,88.255628443,1,1
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1082,1754,0.9896376257,0.8425937234,1.1623426606,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4790,7948,3120268.1522,774050.57495,12578084.245,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4857,17865,1.3836306642,0.5697357868,3.360213382,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1082,420,1.0028537538,0.8430179721,1.1929943192,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4787,1791,1.1457316979,0.3234294234,4.0586941963,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4842,4210,0.7109545848,0.4045350294,1.2494750391,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1754,0.0000128055,1.7964968E-6,0.0000912785,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4787,7944,0.8129994304,0.4009241886,1.6486111156,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4842,17834,0.5784698389,0.3765562108,0.8886518,1,1
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,1082,420,0.9987572757,0.8463987841,1.1785415037,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4787,1791,0.5082158841,0.1292959703,1.9976135699,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,4842,4210,0.5235779957,0.2838185234,0.9658774711,1,1
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1082,1754,0.0000102489,1.4414425E-6,0.0000728711,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4787,7944,0.6237101839,0.277179523,1.4034745037,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4842,17834,0.4258302,0.2662357798,0.6810931248,1,1
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1082,420,1.0004206608,0.833837328,1.2002838744,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4787,1791,0.5266595726,0.133301838,2.0807687992,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4842,4210,0.5574437392,0.3012240105,1.0316027657,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1082,1754,0.0000100302,1.407856E-6,0.0000714596,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4787,7944,0.6211390535,0.2747710748,1.4041278692,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4842,17834,0.4197719919,0.2609599469,0.6752320701,1,1
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1082,420,1.002323061,0.8476820242,1.1851749711,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4787,1791,0.5139642167,0.1315381691,2.0082324235,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4842,4210,0.5314541318,0.284563416,0.9925502658,1,1
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1082,1754,0.0000102178,1.4365407E-6,0.0000726769,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4787,7944,0.6242655934,0.2775645775,1.4040247305,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4842,17834,0.4247182961,0.2661187115,0.6778389614,1,1
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1082,420,0.9979435973,0.845358582,1.1780698093,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4787,1791,0.5097477602,0.1297024745,2.0033756489,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4842,4210,0.5428098885,0.2945503565,1.0003130824,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1082,1754,9.5890276E-6,1.3484422E-6,0.0000681894,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4787,7944,0.6261095866,0.2783476359,1.4083583403,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4842,17834,0.4334076944,0.2702517136,0.6950639724,1,1
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1082,420,1.002259782,0.8354655324,1.2023532172,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4787,1791,0.5241725786,0.1333336608,2.0606716299,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4842,4210,0.576885488,0.3094116007,1.0755797955,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1082,1754,9.4208527E-6,1.3215752E-6,0.0000671566,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4787,7944,0.6271287691,0.2779033342,1.4152060973,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4842,17834,0.428688908,0.2661680728,0.6904441162,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1077,419,2.4032327428,0.3024090407,19.098396008,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4773,1788,0.7074346136,0.3528699791,1.4182666767,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4737,4089,0.812965578,0.6599886274,1.0014006356,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1749,0.9004241038,0.3723926368,2.1771739999,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4773,7848,0.3984307459,0.2615970529,0.6068381027,1,1
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4737,17258,0.5875980678,0.5043824948,0.6845429666,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1077,419,2.350267754,0.287241103,19.23039028,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4773,1788,1.1286319704,0.52661148,2.4188802807,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4737,4089,0.9409690042,0.7334658083,1.207176472,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1077,1749,0.7964768268,0.3062596437,2.071364441,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4773,7848,0.5668278108,0.3376862617,0.9514564363,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4737,17258,0.6708209865,0.5510829599,0.8165754137,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1077,419,2.4124628056,0.2946500668,19.752165175,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4773,1788,1.1621469883,0.5422384335,2.4907596716,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4737,4089,0.9903980117,0.7715990622,1.2712408163,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1077,1749,0.7879780919,0.3032408954,2.0475782875,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4773,7848,0.5594115224,0.3328352655,0.9402286471,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4737,17258,0.6549171765,0.5367008951,0.799172336,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1077,419,2.360590571,0.2884241408,19.320115955,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4773,1788,1.1464982888,0.5342668168,2.4603031387,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4737,4089,0.9593134127,0.7434336006,1.2378808586,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1077,1749,0.7932115109,0.3049014489,2.0635667797,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4773,7848,0.5681227694,0.338397723,0.9537992109,1,1
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4737,17258,0.6690996178,0.5504038765,0.8133923427,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1077,419,2.3598719534,0.2882809637,19.317944426,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4773,1788,1.129845426,0.5272106704,2.4213293819,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4737,4089,0.9561712381,0.7443875437,1.2282089407,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1077,1749,0.8001195387,0.3076471729,2.0809268946,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4773,7848,0.5678108874,0.3382495412,0.953169671,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4737,17258,0.6751551268,0.5546050402,0.8219082268,1,1
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1077,419,2.4088213362,0.2939435187,19.73991553,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4773,1788,1.1682670062,0.5447472598,2.5054697809,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4737,4089,1.0146282511,0.7865899012,1.3087766399,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1077,1749,0.7894728905,0.3036820778,2.0523682179,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4773,7848,0.562793589,0.3347222097,0.9462671273,1,1
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4737,17258,0.6585955514,0.5400753705,0.8031251265,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1070,415,1.3314077976,0.4513309396,3.9275985046,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4753,1779,1.0608442859,0.6360204024,1.769425312,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4688,4051,0.8096207305,0.6841610052,0.9580869449,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1742,0.6016075407,0.3470167664,1.0429802478,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4753,7868,1.0162296263,0.7567993034,1.3645924999,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4688,17483,0.7997357112,0.7034250913,0.9092328603,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,1070,415,1.6771002196,0.5050897356,5.5686444374,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4753,1779,1.1441746573,0.6643426783,1.9705728522,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,4688,4051,1.0052480443,0.8034461437,1.2577366119,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1070,1742,0.8121563166,0.4042705478,1.6315754045,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4753,7868,1.1120981646,0.7998028366,1.5463340101,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4688,17483,0.9637399955,0.7958881281,1.1669916236,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1070,415,1.7365430599,0.5235304887,5.7600882169,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4753,1779,1.1875668409,0.6879270205,2.0500939192,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4688,4051,1.0500698831,0.8464635032,1.3026512724,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1070,1742,0.8039518492,0.3997892415,1.616698272,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4753,7868,1.0990321716,0.7901304643,1.5286990803,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4688,17483,0.9439368746,0.7734595702,1.1519888791,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1070,415,1.6962866172,0.5098134812,5.6440019613,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4753,1779,1.1833806428,0.6869507358,2.0385592049,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4688,4051,1.047679923,0.8369798528,1.3114213172,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1070,1742,0.8046167791,0.3995662938,1.6202772138,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4753,7868,1.116375118,0.8029659617,1.5521123729,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4688,17483,0.9564087169,0.7897670283,1.1582119803,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1070,415,1.6859275893,0.5075916827,5.5996816596,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4753,1779,1.1468129405,0.6659769708,1.9748129111,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4688,4051,1.0233355419,0.8177342479,1.2806307601,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1070,1742,0.8165896115,0.4064215579,1.6407067506,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4753,7868,1.1156637435,0.8022812517,1.5514579034,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4688,17483,0.9726381005,0.8030258998,1.1780751714,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1070,415,1.7393996263,0.5231265975,5.7835160256,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4753,1779,1.2096836154,0.7010887986,2.08723125,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4688,4051,1.0948122708,0.8816606699,1.3594957212,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1070,1742,0.8022086945,0.3980589329,1.6166922441,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4753,7868,1.1107356764,0.7985003317,1.545063532,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4688,17483,0.9478558939,0.7761353452,1.1575697477,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1060,415,3.2061429732,0.9854623267,10.430995165,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4658,1753,1.6979989037,1.1216160921,2.5705767753,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4585,4035,1.3438045023,1.0936891985,1.6511185654,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1060,1740,2.0989162836,1.2143249181,3.627900161,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4658,7884,2.0758153259,1.6223601312,2.6560127954,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4585,17626,1.615324708,1.3923057005,1.8740668167,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1060,415,2.4136776239,0.6215197974,9.3735383759,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4658,1753,1.162267084,0.7070336538,1.9106088759,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4585,4035,1.212002854,0.9468963608,1.5513323093,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1060,1740,1.4515116058,0.7202268778,2.9253086864,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4658,7884,1.6733671954,1.2668242281,2.2103759217,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4585,17626,1.4728160467,1.2151755482,1.7850812671,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1060,415,2.4023639745,0.6170446401,9.3532174025,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4658,1753,1.1585925314,0.7056472027,1.9022772976,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4585,4035,1.2145868557,0.9502568782,1.5524446746,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1060,1740,1.4545390297,0.721938988,2.9305576012,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4658,7884,1.677382062,1.2681540017,2.2186663277,1,1
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4585,17626,1.4736340129,1.2115764437,1.7923732467,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1060,415,2.4156400576,0.6219300761,9.3825931763,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4658,1753,1.1690917684,0.7099689273,1.9251202558,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4585,4035,1.221500704,0.9532533499,1.5652333873,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1060,1740,1.4499231809,0.7193331132,2.9225364324,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4658,7884,1.6736987508,1.2671803649,2.2106304565,1,1
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4585,17626,1.4710974515,1.2136379414,1.7831740735,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1060,415,2.4070253116,0.6198048434,9.3477340692,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4658,1753,1.1601614123,0.7057327138,1.9072015174,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4585,4035,1.196202924,0.9346984718,1.5308695569,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1060,1740,1.4492596135,0.7191185205,2.9207333246,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4658,7884,1.6705991291,1.2646743258,2.20681435,1,1
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4585,17626,1.464641706,1.2087146072,1.7747575102,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1060,415,2.4068100105,0.6180447065,9.3726786514,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4658,1753,1.1685674019,0.7106986198,1.9214189176,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4585,4035,1.2144864451,0.9493454681,1.5536781654,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1060,1740,1.4495160785,0.7193471685,2.9208384404,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4658,7884,1.6730547035,1.2647840461,2.2131146022,1,1
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4585,17626,1.4605288853,1.2009791561,1.7761712297,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1038,402,1.2220608244,0.5319268582,2.8075902456,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4544,1724,0.8109283607,0.5877149697,1.118917911,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4401,3940,1.2465269123,0.9938137385,1.5635015727,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1736,1.6011257772,0.9350171339,2.741771954,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4544,7859,2.0259646513,1.5745753364,2.6067554049,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4401,17565,1.9078309184,1.6128698646,2.2567343424,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1038,402,1.4570475744,0.591245814,3.5907021813,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4544,1724,0.7523826002,0.5209317481,1.0866674553,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4401,3940,1.1936503337,0.9117990298,1.5626262723,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1038,1736,1.6770757175,0.8932407909,3.1487399491,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4544,7859,2.0851517229,1.5768826746,2.7572487018,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4401,17565,1.7529943482,1.4115135326,2.177088008,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1038,402,1.5106871408,0.6134016891,3.7205238883,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4544,1724,0.7801222182,0.5416849675,1.1235140567,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4401,3940,1.2401739475,0.9510468916,1.617198304,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1038,1736,1.660761832,0.8839740793,3.1201478947,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4544,7859,2.0600497893,1.5555074764,2.7282447683,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4401,17565,1.7181633859,1.3783975122,2.1416793012,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1038,402,1.4638137053,0.5940314404,3.6071332566,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4544,1724,0.7626636484,0.5272977686,1.1030879992,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4401,3940,1.2176925826,0.9301642812,1.5941003709,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1038,1736,1.6730725594,0.8909582667,3.1417541018,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4544,7859,2.0853608786,1.577332579,2.7570152622,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4401,17565,1.7479291832,1.4069288396,2.1715785073,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1038,402,1.4545579035,0.5902548602,3.5844494256,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4544,1724,0.7514957776,0.5203580944,1.0853024289,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4401,3940,1.1833299897,0.9026144466,1.5513488289,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1038,1736,1.6743289993,0.8918075511,3.1434782025,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4544,7859,2.0840869613,1.5761345707,2.7557408757,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4401,17565,1.747838994,1.4066407688,2.1717990953,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1038,402,1.5133193994,0.6144851865,3.7269175156,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4544,1724,0.7887541549,0.5472207456,1.1368960733,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4401,3940,1.2519530352,0.9589392597,1.6345001902,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1038,1736,1.654366055,0.8804982893,3.1083842832,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4544,7859,2.0582149782,1.5542738931,2.725548512,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4401,17565,1.7073047893,1.3685672934,2.1298840456,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,1017,393,0.9046661393,0.4816987118,1.6990305424,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,4485,1700,1.1935625425,0.8673503238,1.6424638393,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,4537,3999,1.6874973314,1.3535870138,2.1037784896,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,1017,1696,0.8614212455,0.5782725195,1.2832125635,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4485,7737,0.8634049775,0.722256333,1.032137928,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,4537,17577,1.4691649147,1.2690316343,1.700860316,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,1017,393,0.7473995762,0.3630597627,1.5386065434,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,4485,1700,1.2462338589,0.8667261843,1.7919140546,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,4537,3999,1.4264189115,1.1077332135,1.8367878532,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,1017,1696,0.8200133418,0.5214785319,1.2894526611,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,4485,7737,0.8189538776,0.6667472542,1.0059065851,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,4537,17577,1.2255288448,1.0226574819,1.4686451486,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,1017,393,0.7440940013,0.361019906,1.5336436397,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,4485,1700,1.2391513214,0.8624488137,1.780390874,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,4537,3999,1.4179621176,1.1022487877,1.8241041308,1,1
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,1017,1696,0.8207307822,0.522033693,1.2903362865,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,4485,7737,0.819253519,0.6662301878,1.0074240716,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,4537,17577,1.225138994,1.0203803943,1.4709862743,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,1017,393,0.7409427124,0.3600255342,1.5248810178,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,4485,1700,1.2202793609,0.8477127343,1.7565876486,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,4537,3999,1.3870295947,1.0759484269,1.7880514052,1,1
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,1017,1696,0.8237097106,0.5238298479,1.2952635098,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,4485,7737,0.8167057654,0.6645757376,1.0036603345,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,4537,17577,1.2316002944,1.0278514192,1.4757378905,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,1017,393,0.7452919671,0.3615149732,1.5364788666,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,4485,1700,1.2428236439,0.8643458189,1.7870284971,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,4537,3999,1.4063597306,1.0925320092,1.8103338622,1,1
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,1017,1696,0.8169374612,0.5195646798,1.2845115179,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,4485,7737,0.8171579995,0.6653287877,1.0036349073,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,4537,17577,1.2194298512,1.0179200162,1.460831046,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,MPCD,1017,393,0.7421699228,0.3597148782,1.5312577481,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Marketscan,4485,1700,1.2210948665,0.8490329586,1.7562011673,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs DMARD,Medicare,4537,3999,1.3713683112,1.0652638864,1.7654320857,1,1
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,MPCD,1017,1696,0.8192711266,0.5212021575,1.2878019963,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Marketscan,4485,7737,0.8132468141,0.6609985981,1.0005624558,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex,",TNF vs NSAID or no exposure,Medicare,4537,17577,1.2201437097,1.0168532148,1.4640762804,1,1
